These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27596055)

  • 1. High-dose Cepharanthin for pediatric chronic immune thrombocytopenia in Japan.
    Yamazaki T; Shibuya A; Ishii S; Miura N; Ohtake A; Sasaki N; Araki R; Ota Y; Fujiwara M; Miyajima Y; Uetake K; Hamahata K; Kato K; Kawakami K; Toyoda H; Moriguchi N; Okada M; Nishi M; Ogata Y; Takimoto T; Ohga S; Ohta S; Amemiya S
    Pediatr Int; 2017 Mar; 59(3):303-308. PubMed ID: 27596055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].
    Takahata M; Hashino S; Fujimoto K; Endo T; Kobayashi N; Kurosawa M; Iwasaki H; Miyake T; Kohda K; Maekawa I; Sasagawa H; Tsustumi Y; Miyagishima T; Tanaka J; Imamura M; Teshima T
    Rinsho Ketsueki; 2012 Dec; 53(12):1983-90. PubMed ID: 23318963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura.
    Sato T; Morita I; Fujita H; Ono M; Kimishima A; Tomiyama J; Murota S
    Platelets; 2001 May; 12(3):156-62. PubMed ID: 11304417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of chronic idiopathic thrombocytopenic purpura in children.
    Bansal D; Bhamare TA; Trehan A; Ahluwalia J; Varma N; Marwaha RK
    Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-D treatment for pediatric immune thrombocytopenia: Is the bad reputation justified?
    Yacobovich J; Abu-Ahmed S; Steinberg-Shemer O; Goldberg T; Cohen M; Tamary H
    Semin Hematol; 2016 Apr; 53 Suppl 1():S64-6. PubMed ID: 27312170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura].
    Nakayama S; Matsushita A; Ichiba S; Nagai K
    Rinsho Ketsueki; 1992 Mar; 33(3):408-9. PubMed ID: 1578649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
    Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
    Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.
    González-López TJ; Alvarez-Román MT; Pascual C; Sánchez-González B; Fernández-Fuentes F; Jarque I; Pérez-Rus G; Pérez-Crespo S; Bernat S; Hernández-Rivas JA; Andrade MM; Cortés M; Gómez-Nuñez M; Olivera P; Martínez-Robles V; Fernández-Rodríguez A; Fuertes-Palacio MA; Fernández-Miñano C; de Cabo E; Fisac R; Aguilar C; Bárez A; Peñarrubia MJ; García-Frade LJ; González-Porras JR
    Eur J Haematol; 2016 Sep; 97(3):297-302. PubMed ID: 26709028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A for persistent or chronic immune thrombocytopenia in children.
    Liu AP; Cheuk DK; Lee AH; Lee PP; Chiang AK; Ha SY; Tsoi WC; Chan GC
    Ann Hematol; 2016 Oct; 95(11):1881-6. PubMed ID: 27525725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
    Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial hemorrhage in childhood immune thrombocytopenic purpura.
    Choudhary DR; Naithani R; Mahapatra M; Kumar R; Mishra P; Saxena R
    Pediatr Blood Cancer; 2009 Apr; 52(4):529-31. PubMed ID: 19058201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute immune thrombocytopenic purpura in children and adolescents in South Dakota 1998-2004.
    Tancabelic J; Stout LA; Wetering J
    S D J Med; 2005 Nov; 58(11):465-8. PubMed ID: 16502732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
    Zheng J; Ma JY; Su Y; Yang J; Zhang RD; Zhou X; Wu RH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):393-8. PubMed ID: 24763011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in children.
    Yadav D; Chandra J; Sharma S; Singh V
    J Trop Pediatr; 2010 Dec; 56(6):446-7. PubMed ID: 20388659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.